Published in
Wiley, Diabetes, Obesity and Metabolism, 7(18), p. 711-715, 2016
DOI: 10.1111/dom.12620
Links
Tools
Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial
Journal article published in 2016 by
A. O. Stirban,
M. Andjelkovic,
T. Heise,
L. Nosek,
A. Fischer,
A. Gastaldelli 
,
M. Herz
,
M. Herz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 